Item 16. FORM 10-K SUMMARY

Not applicable.


			Dow Inc. and Subsidiaries
			The Dow Chemical Company and Subsidiaries
			Valuation and Qualifying Accounts			Schedule II


(In millions) For the years ended Dec 31,	2025		2024		2023
Accounts Receivable - Allowance for Doubtful Receivables
Balance at beginning of year	$	95	$	81	$	110
Additions charged to expenses 1	23		28		21

Deductions from reserves 2	(59)		(14)		(50)
Balance at end of year	$	59	$	95	$	81
Inventory - Obsolescence Reserve
Balance at beginning of year	$	88	$	70	$	57
Additions charged to expenses	14		27		20
Deductions from reserves 3	(2)		(9)		(7)
Balance at end of year	$	100	$	88	$	70
Reserves for Other Investments and Noncurrent Receivables
Balance at beginning of year	$	1,650	$	1,751	$	1,950
Additions charged to expenses 4	5		14		31
Deductions from reserves 5	(214)		(115)		(230)
Balance at end of year	$	1,441	$	1,650	$	1,751
Deferred Tax Assets - Valuation Allowance
Balance at beginning of year	$	2,748	$	2,948	$	1,269
Additions charged to expenses 6	633		55		1,864
Deductions from reserves	(331)		(255)		(185)
Balance at end of year	$	3,050	$	2,748	$	2,948

1.Additions included a $23 million reclassification from "Reserves for Other Investments and Noncurrent Receivables" in 2024.

2.Deductions included write-offs, recoveries, currency translation adjustments and other miscellaneous items, including a $23 million reclassification to "Reserves for Other Investments and Noncurrent Receivables" in 2023.

3.Deductions included disposals and currency translation adjustments.

4.Additions included a $23 million reclassification from "Accounts Receivable - Allowance for Doubtful Receivables" in 2023.

5.Deductions included $81 million related to the Company’s investment in DowAksa, which was converted to cash in 2025. See Note 4 to the Consolidated Financial Statements for additional information. Deductions also included a $23 million reclassification to "Accounts Receivable - Allowance for Doubtful Receivables" in 2024, $143 million related to the Company's investment in a previously held equity method investment, which was converted to cash, in 2023, and $77 million in 2025, 2024 and 2023 related to the Company's investment in Sadara. See Note 11 to the Consolidated Financial Statements for additional information.

6.Additions in 2023 include increases in valuation allowances related to foreign tax assets that are expected to expire without being utilized.

Table of Contents


						Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries
						Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on February 3, 2026.


DOW INC.
THE DOW CHEMICAL COMPANY

/s/ ANDREA L. DOMINOWSKI
Andrea L. Dominowski, Controller and Vice President of Controllers (Authorized Signatory and Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below on February 3, 2026, by the following persons on behalf of the registrant and in the capacities indicated.


/s/ SAMUEL R. ALLEN						/s/ JEFF M. FETTIG
Samuel R. Allen, Director, Dow Inc.						Jeff M. Fettig, Director, Dow Inc.

/s/ GAURDIE E. BANISTER JR.						/s/ JIM FITTERLING
Gaurdie E. Banister Jr., Director, Dow Inc.						Jim Fitterling, Director, Chair and Chief Executive Officer, Dow Inc. and TDCC (Principal Executive Officer)

/s/ WESLEY G. BUSH						/s/ JACQUELINE C. HINMAN
Wesley G. Bush, Director, Dow Inc.						Jacqueline C. Hinman, Director, Dow Inc.

/s/ RICHARD K. DAVIS						/s/ LUIS ALBERTO MORENO MEJIA
Richard K. Davis, Lead Director, Dow Inc.						Luis Alberto Moreno Mejia, Director, Dow Inc.

/s/ JERRI DEVARD						/s/ JEFFREY L. TATE
Jerri DeVard, Director, Dow Inc.						Jeffrey L. Tate, Chief Financial Officer, Dow Inc. and TDCC; Director, TDCC (Principal Financial Officer)

/s/ DEBRA L. DIAL						/s/ JILL S. WYANT
Debra L. Dial, Director, Dow Inc.						Jill S. Wyant, Director, Dow Inc.

/s/ ANDREA L. DOMINOWSKI						/s/ DANIEL W. YOHANNES
Andrea L. Dominowski, Controller and Vice President of Controllers, Dow Inc. and TDCC (Authorized Signatory and Principal Accounting Officer)						Daniel W. Yohannes, Director, Dow Inc.

Table of Contents


Dow Inc. and Subsidiaries The Dow Chemical Company and Subsidiaries
Trademark Listing

The following trademarks or service marks of The Dow Chemical Company and certain affiliated companies of Dow appear in this report: ACOUSTICRYL, ACRYSOL, ACUSOL, AMPLIFY, AQUASET, AVANSE, CARBOWAX, DECARBIA, DOW, DOWANOL, DOWFROST, DOWSIL, DOWTHERM, ELEVATE, EVOQUE, FASTRACK, FORMASHIELD, MAINCOTE, PRIMAL, RENUVA, REVOLOOP, RHOPLEX, SENTRY, SILASTIC, SPECFLEX, SUNSPHERES, SYL-OFF, TAMOL, TERGITOL, TRITON, UCAR, UCARSOL, UCON, VERSENE, WALOCEL

The following registered service mark of American Chemistry Council in the United States appears in this report:

Responsible Care®

The following trademark of the Business Intelligence Group™ appears in this report: BIG Innovation Awards

The following trademark of Clarivate™ appears in this report: Top 100 Global Innovators™

The following trademark of The Edison Awards™ appears in this report: Edison Awards™

The following trademarks and registered trademarks of Great Place to Work® Institute, Inc. appears in this report: Great Place to Work®, Fortune 100 Best Companies to Work For®

The following trademarks of Ti Gotham Inc. appears in this report: PEOPLE®, PEOPLE® Companies that Care

The following registered trademark of InspereX Holdings LLC appears in this report: InterNotes®

® ™ Trademark of The Dow Chemical Company ("TDCC") or an affiliated company, except as otherwise specified.

Previous: Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES